GA
Greytown Advisors Portfolio holdings
AUM
$170M
This Quarter Return
+8.03%
1 Year Return
+15.77%
3 Year Return
+13.89%
5 Year Return
+54.69%
10 Year Return
–
AUM
$178M
AUM Growth
+$178M
(-2.8%)
Cap. Flow
-$18.8M
Cap. Flow
% of AUM
-10.6%
Top 10 Holdings %
Top 10 Hldgs %
68.04%
Holding
88
New
4
Increased
9
Reduced
45
Closed
11
Top Buys
| 1 |
Flutter Entertainment
FLUT
|
$832K |
| 2 |
Vanguard Health Care ETF
VHT
|
$666K |
| 3 |
First Trust North American Energy Infrastructure Fund
EMLP
|
$517K |
| 4 |
Global X MLP & Energy Infrastructure ETF
MLPX
|
$393K |
| 5 |
NVIDIA
NVDA
|
$270K |
Top Sells
| 1 |
Vanguard Mega Cap Growth ETF
MGK
|
$3.38M |
| 2 |
Vanguard Mega Cap Value ETF
MGV
|
$2.38M |
| 3 |
Vanguard FTSE Europe ETF
VGK
|
$1.76M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
$1.26M |
| 5 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
$1.23M |
Sector Composition
| 1 | Financials | 5.9% |
| 2 | Healthcare | 1.89% |
| 3 | Consumer Discretionary | 1.46% |
| 4 | Technology | 1.44% |
| 5 | Communication Services | 1.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vodafone
VOD
$28.2B
| $92.2K | 0.05% |
10,363
-4,200
| -29% | -$37.4K |
|
|
MIN
77
MFS Intermediate Income Trust
MIN
$306M
| $76.1K | 0.04% |
28,615
| – | – |
|
|
AMJ
78
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| – | – |
-48,314
| Closed | -$1.23M |
|
79
AT&T
T
$208B
| – | – |
-10,994
| Closed | -$184K |
|
80
VanEck Rare Earth/Strategic Metals ETF
REMX
$713M
| – | – |
-7,620
| Closed | -$469K |
|
81
Procter & Gamble
PG
$370B
| – | – |
-1,499
| Closed | -$220K |
|
82
Pfizer
PFE
$141B
| – | – |
-7,040
| Closed | -$203K |
|
83
PepsiCo
PEP
$203B
| – | – |
-1,292
| Closed | -$221K |
|
84
McDonald's
MCD
$226B
| – | – |
-916
| Closed | -$272K |
|
85
Alphabet (Google) Class A
GOOGL
$2.79T
| – | – |
-1,766
| Closed | -$247K |
|
86
Vanguard ESG US Stock ETF
ESGV
$11.1B
| – | – |
-2,910
| Closed | -$248K |
|
87
CVS Health
CVS
$93B
| – | – |
-3,918
| Closed | -$309K |
|
88
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-3,938
| Closed | -$202K |
|